• Home
  • Search
  • CT4CMS: Preoperative Computed Tomography-Based Consensus Molecular Subtyping Prediction in Colorectal Cancer Using Interpretable Deep Learning
  • https://doi.org/10.64898/2026.03.08.26347898Copy DOI Icon

CT4CMS: Preoperative Computed Tomography-Based Consensus Molecular Subtyping Prediction in Colorectal Cancer Using Interpretable Deep Learning

  • Mar 10, 2026
  • medRxiv
  • Xianrui Zhang +17 more
Show More
  • Abstract
  • Literature Map
  • Similar Papers
Abstract

Abstract Consensus molecular subtyping (CMS) defines the transcriptomic taxonomy of colorectal cancer (CRC) and guides precision therapy. Although current approaches can predict CMS from histopathology, they rely on surgical specimens, limiting their preoperative applicability. In this study, we developed a deep learning model to infer CMS directly from preoperative computed tomography (CT) scans, enabling noninvasive molecular stratification of CRC. A multi-institutional cohort of 2,444 CRC patients was collected from the Sixth Affiliated Hospital of Sun Yat-sen University and Liaoning Cancer Hospital, comprising a discovery cohort ( n = 416), an internal validation cohort ( n = 1,671), and an external validation cohort ( n = 357). To achieve robust feature extraction, a self-supervised 3D representation learning network was first pretrained on large-scale public CT datasets to capture generalizable imaging features. These representations were subsequently integrated into a multi-instance learning (MIL) classifier for CMS prediction, with attention mechanisms to enhance interpretability. Model performance was evaluated by cross-validation on the discovery cohort and verified on the two validation cohorts. CT4CMS demonstrated strong performance in predicting CMS subtypes directly from CT scans, achieving a cross-validation AUC of 0.867. In both validation cohorts, patients predicted as CMS4 exhibited significantly poorer disease-free survival yet derived substantial benefit from adjuvant chemotherapy, consistent with transcriptome-defined subtyping trends observed in the discovery cohort. Interpretability analysis revealed distinct subtype-specific radiomic features, suggesting that CT-derived imaging features capture underlying molecular characteristics and enable CMS classification. Overall, this study establishes a noninvasive and interpretable deep learning framework for CMS prediction in CRC, paving the way for imaging-based molecular stratification and personalized therapeutic decision-making.

Similar Papers
  • Research Article
  • Citations14

Computed tomography-based radiomics nomogram for the preoperative prediction of perineural invasion in colorectal cancer: a multicentre study.

  • Aug 12, 2022
  • Abdominal Radiology
  • Qiaoling Chen +8
  • Research Article
  • Citations167

Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.

  • Sep 01, 2016
  • JAMA Oncology
  • Nan Song +11
  • Research Article
  • Citations20

Development and Validation of Contrast-Enhanced CT-Based Deep Transfer Learning and Combined Clinical-Radiomics Model to Discriminate Thymomas and Thymic Cysts: A Multicenter Study

  • Nov 10, 2023
  • Academic radiology
  • Yuhua Yang +10
  • Research Article
  • Citations2

2.5D peritumoural radiomics predicts postoperative recurrence in stage I lung adenocarcinoma.

  • Aug 29, 2024
  • Frontiers in oncology
  • Haimei Lan +6
  • Research Article
  • Citations3

Computed tomography-based radiomics nomogram for the pre-operative prediction of BRAF mutation and clinical outcomes in patients with colorectal cancer: a double-center study.

  • May 17, 2023
  • The British journal of radiology
  • Manman Li +8
  • Research Article
  • Citations58

MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study.

  • Feb 11, 2020
  • Journal of Magnetic Resonance Imaging
  • Yong'Ai Li +21
  • PDF
  • Research Article
  • Citations10

A radiomics nomogram for predicting cytokeratin 19-positive hepatocellular carcinoma: a two-center study.

  • Apr 27, 2023
  • Frontiers in Oncology
  • Liqing Zhang +4
  • Supplementary Content
  • Citations51

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach

  • Nov 24, 2021
  • World Journal of Clinical Oncology
  • Guillermo Valenzuela +5
  • Research Article
  • Citations137

The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial

  • Nov 01, 2018
  • Annals of Oncology
  • J.K Mooi +12
  • Research Article
  • Citations2

Enrichment of germline DNA-repair gene mutations in patients with colorectal cancer.

  • May 20, 2017
  • Journal of Clinical Oncology
  • Saud H Aldubayan +11
  • Research Article
  • Citations17

CT-based whole lung radiomics nomogram: a tool for identifying the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease.

  • Jan 12, 2024
  • European radiology
  • Xiaoqing Lin +11
  • Research Article
  • Citations15

Predicting the Ki-67 proliferation index in pulmonary adenocarcinoma patients presenting with subsolid nodules: construction of a nomogram based on CT images.

  • Jan 01, 2022
  • Quantitative Imaging in Medicine and Surgery
  • Jing Yan +7
  • Research Article

Abstract 5059: Robust single sample consensus molecular subtype classification for primary and metastatic colorectal cancer

  • Mar 22, 2024
  • Cancer Research
  • Andrew J Sedgewick +3
  • Research Article
  • Citations19

Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients

  • Oct 07, 2022
  • Transplantation Direct
  • Sophie C Frölke +10
  • Research Article

Abstract 5743: Comprehensive next generation sequencing profiling in combination with transcriptomic-based tumor molecular subtyping and harmonized TMB calculation using paired specimens from late-stage CRC patients

  • Jun 15, 2022
  • Cancer Research
  • Danyi Wang +4
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.